Anti-HIV-1 activities of hemslecins A and B

Chinese Journal of Natural Medicines

Volumn 6, Issue 3, 2008, Pages 214-218

  Tian, Ren Rong ^a,e   Chen, Jian Chao ^b,d   Zhang, Gao Hong ^a   Qiu, Ming Hua ^b   Wang, Yun Hua ^a,d   Du, Li ^c,d   Shen, Xu ^c   Liu, Nai Fa ^e   Zheng, Yong Tang ^a  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b KUNMING INSTITUTE OF BOTANY   (China)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^d UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^e LANZHOU UNIVERSITY   (China)

Author keywords

Anti HIV agents; Hemslecin; Hemsleya jinfushanensis; Natural products; Tritererpenoids

Indexed keywords

ANTIGEN P24; HEMSLECIN A; HEMSLECIN B; INDINAVIR; INTEGRASE; PROTEINASE; RNA DIRECTED DNA POLYMERASE; TRITERPENOID; ZIDOVUDINE; ZINC;

ANTIVIRAL ACTIVITY; ARTICLE; CELL FUSION; CHINESE MEDICINE; COCULTURE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; HEMSLEYA JINFUSHANENSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; MEDICINAL PLANT; NONHUMAN; SYNCYTIUM; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS INHIBITION;

EID: 44949246510     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: 10.3724/SP.J.1009.2008.00214     Document Type: Article

References (18)

1. Gallant JE. Antiretroviral drug resistance and resistance testing [J]. Top HIV Med, 2005, 13: 138-142.
2. Hawkins T. Appearance-related side effects of HIV-1 treatment [J]. AIDS Patient Care STDS, 2006, 20: 6-18.
3. Asres K, Seyoum A, Veeresham C, et al. Naturally derived anti-HIV agents[J]. Phytother Res, 2005, 19(7):557-581.
4. Ikeda T, Yokomizo K, Okawa M, et al. Anti-herpes virus type 1 activity of oleanane-type triterpenoids [J]. Biol Pharm Bull, 2005, 28(9): 1779-1781.
5. Okamoto T, Kajino K, Hino O. Hepatoprotective drugs for the treatment of virus-induced chronic hepatitis: from hypercarcinogenic state to hypocarcinogenic state [J]. Jpn J Pharmacol, 2001, 87: 177-180.
6. Jiangsu Medical College. Encyclopedia of Chinese Materia Medica[M], Vol. 1, Shanghai Scientific Technology Press, Shanghai, China, 1997, 1358-1359.
7. Pharmacopoeia of China[M]. Part 1, People's Health Press, Beijing, China, 1997, 531-534.
8. Nie RL, Chen ZL. The research history and present status on the chemical components of genus Hemsleya (Cucurbitaeae) [J]. Acta Bot Yunnan, 1986, 8(2): 115-124.
9. Chen JC, Niu XM, Li ZR, et al. Four new cucurbitane glycosides from Hemsleya jinfushanensis [J]. Planta Med, 2005, 71: 983-986.
10. Liu GJ, Wang JP, Xiao JC, et al. Preparation and characterization of three monoclonal antibodies against HIV-1 p24 capsid protein [J]. Cell Mol Immunol, 2007, 4(3): 203-208.
11. Wang YH, Wang RR, Yang LM, et al. Expression and purification of HIV-1 protease and establishment of a method fro protease inhibitor screening[J]. Virol Sin, 2007, 21: 126-130.
12. Zhang GH, Wang Q, Chen JJ, et al. The anti-HIV-1 effect of scutellarin[J]. Biochem Biophys Res Commun, 2005, 334(3):812-816.
13. Yang LM, Wang RR, Li JJ, et al. Anti-HIV-1 activities of four berberine Compounds in vitro[J]. Chin J Nat Med, 2007, 5(3): 225-228.
14. Wang JH, Kong J, Li W, et al. A beta-galactose-specific lectin isolated from the marine worm Chaetopterus variopedatus possesses anti-HIV-1 activity [J]. Comp Biochem Physiol C Toxicol Pharmacol, 2006, 142(1-2): 111-117.
15. Wang YH, Tang JG, Wang RR, et al. Flazinamide, a novel β-carboline compound with anti-HIV actions [J]. Biochem Biophys Res Commun, 2007, 355(4): 1091-1095.
16. Wang YH, Wang BR, Yang LM, et al. Establishment of a screening method for HIV-1 NCp7 inhibitors. Chin Pharm Bull, 2008, 24(1): 136-139.
17. Sun IC, Kashiwada Y, Morris-Natschke SL, et al. Plant-derived terpenoids and analogues as anti-HIV agents[J]. Curr Top Med Chem, 2003, 3(2): 155-169.
18. Chen JC, Zhang GH, Zhang ZQ, et al. Octanorcucurbitane and cucurbitane triterpenoids from the tubers of Hemsleya endecaphylla with HIV-1 inhibitory activity[J]. J Nat Prod., 2008, 71(1): 153-155.